An extensive research project has mapped out quality of life issues associated with Huntington’s disease, focusing on matters most important to…
Magdalena Kegel
Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Magdalena Kegel
A survey of 1,700 Huntington’s disease patients that questioned issues such as symptoms, treatment, and disease management, revealed some surprising…
A recent review summarizes the scientific literature on behavioral and psychiatric symptoms of Huntington’s disease, noting that plenty of research…
Researchers have developed a new gene-editing tool that may improve the precision of future gene therapy efforts in Huntington’s disease,…
Mice models of Huntington’s disease, infected with a parasite commonly found in humans, react in a different way to the…
Attempts to block the activity of the mutant huntingtin gene, which causes Huntington’s disease, may have taken a big step forward.
Using a new Huntington’s disease model featuring two types of disease affected neurons grown together in the lab, researchers showed…
Inflammatory processes in both the brain and the rest of the body are likely an integral part of Huntington’s disease,…
Researchers at the University of Auckland in New Zealand showed that the pattern of neuronal loss in three cortical…
Researchers at Icahn School of Medicine at Mount Sinai in New York have discovered that a protein complex crucial…